β-adrenergic Receptor Polymorphisms and Responses during Titration of Metoprolol Controlled Release/extended Release in Heart Failure* - Concepedia

Concepedia

Publication | Closed Access

β-adrenergic Receptor Polymorphisms and Responses during Titration of Metoprolol Controlled Release/extended Release in Heart Failure*

119

Citations

39

References

2005

Year

Steven G. Terra, Daniel Pauly, Craig R. Lee, J. Herbert Patterson, Kirkwood F. Adams, Richard S. Schofield, Bernadette S. Belgado, Karen Hamilton, Juan M. Aranda, James A. Hill,

Clinical Pharmacology & Therapeutics

Abstract

Patients with the Gly389 variant and Ser49Ser genotype were significantly more likely to require increases in heart failure medications during beta-blocker titration and thus may require more frequent follow-up during titration.

References

	Year	Citations
The 6-minute walk: a new measure of exercise capacity in patients with chronic heart failure. Gordon Guyatt, Michael Sullivan, Penelope J. Thompson, PubMed Heart FailurePhysical ActivityNew MeasureAerobic ExerciseChronic Heart Failure	1985	2.1K
ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary Sharon A. Hunt, David W. Baker, Marshall H. Chin, Journal of the American College of Cardiology Heart FailureChronic Heart FailureHealth PolicyCardiovascular DiseaseOutcomes Research	2001	1.9K
Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Donna Mancini, Howard J. Eisen, William G. Kussmaul, Circulation	1991	1.8K
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) Sharon A. Hunt, David W. Baker, Marshall H. Chin, Circulation	2001	1.4K
Assessment of patient outcome with the Minnesota Living with Heart Failure questionnaire: Reliability and validity during a randomized, double-blind, placebo-controlled trial of pimobendan Thomas S. Rector, Jay N. Cohn American Heart Journal Heart FailureHealth PolicyCardiovascular DiseaseHeart Failure QuestionnairePatient Outcome	1992	995
Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences. Christoph Sachse, Jürgen Brockmöller, Steffen Bauer, PubMed	1997	979
A Gain-of-function Polymorphism in a G-protein Coupling Domain of the Human β1-Adrenergic Receptor Deborah A. Mason, Jason D. Moore, Stuart A. Green, Journal of Biological Chemistry Gain-of-function PolymorphismNeuropeptidesArg-389 ReceptorsCellular PhysiologyMolecular Pharmacology	1999	585
Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme): an international survey Alain Cohen‐Solal, Juan Cosín Aguilar, Rainer Dietz, The Lancet Family MedicinePrimary CareHeart FailureHealth PolicyCardiovascular Disease	2002	536
The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. Shioko Kimura, M Umeno, Radek C. Skoda, PubMed	1989	407
The Effect of Common Polymorphisms of the β<sub>2</sub>-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization Victor Dishy, Gbenga G. Sofowora, Hong‐Guang Xie, New England Journal of Medicine	2001	359

Page 1